Literature DB >> 24482502

Association of a single-nucleotide polymorphism in the SH2B3 gene with JAK2V617F-positive myeloproliferative neoplasms.

Elodie Lesteven1, Marie Picque, Carole Conejero Tonetti, Stéphane Giraudier, Nadine Varin-Blank, Laura Velazquez, Jean-Jacques Kiladjian, Bruno Cassinat, Fanny Baran-Marszak.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24482502     DOI： 10.1182/blood-2013-10-532622

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  4 in total

Review 1.  The role of LNK/SH2B3 genetic alterations in myeloproliferative neoplasms and other hematological disorders.

Authors:  N Maslah; B Cassinat; E Verger; J-J Kiladjian; L Velazquez
Journal:  Leukemia       Date:  2017-05-09       Impact factor: 11.528

2.  Germ line variants predispose to both JAK2 V617F clonal hematopoiesis and myeloproliferative neoplasms.

Authors:  David A Hinds; Kimberly E Barnholt; Ruben A Mesa; Amy K Kiefer; Chuong B Do; Nicholas Eriksson; Joanna L Mountain; Uta Francke; Joyce Y Tung; Huong Marie Nguyen; Haiyu Zhang; Linda Gojenola; James L Zehnder; Jason Gotlib
Journal:  Blood       Date:  2016-06-30       Impact factor: 22.113

3.  Myelodysplastic Syndrome/Acute Myeloid Leukemia Arising in Idiopathic Erythrocytosis.

Authors:  Stephen E Langabeer; Eibhlin Conneally; Catherine M Flynn
Journal:  Case Rep Hematol       Date:  2018-02-22

4.  SH2B3 inactivation through CN-LOH 12q is uniquely associated with B-cell precursor ALL with iAMP21 or other chromosome 21 gain.

Authors:  Paul B Sinclair; Sarra Ryan; Matthew Bashton; Shaun Hollern; Rebecca Hanna; Marian Case; Edward C Schwalbe; Claire J Schwab; Ruth E Cranston; Brian D Young; Julie A E Irving; Ajay J Vora; Anthony V Moorman; Christine J Harrison
Journal:  Leukemia       Date:  2019-02-28       Impact factor: 11.528
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.